Cargando…
Validation of a modified CDC assay and performance comparison with the NeuMoDx™ and DiaSorin® automated assays for rapid detection of SARS-CoV-2 in respiratory specimens
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has spread rapidly around the globe since it was first identified in December of 2019 in Wuhan, China. In a race to contain the infection, researchers and healthcare officials hav...
Autores principales: | Lima, Amorce, Healer, Vicki, Vendrone, Elaine, Silbert, Suzane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657030/ https://www.ncbi.nlm.nih.gov/pubmed/33220549 http://dx.doi.org/10.1016/j.jcv.2020.104688 |
Ejemplares similares
-
New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method
por: Castiglione, Vincent, et al.
Publicado: (2022) -
Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening
por: Heideman, Daniëlle A. M., et al.
Publicado: (2022) -
Analytical and clinical evaluation of DiaSorin Liaison® Calprotectin fecal assay adapted for serum samples
por: Macias‐Muñoz, Laura, et al.
Publicado: (2022) -
Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test
por: Mostafa, Heba H., et al.
Publicado: (2020) -
Clinical Performance Evaluation of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay
por: Meletis, Georgios, et al.
Publicado: (2022)